Salta al contenuto principale
Passa alla visualizzazione normale.

ANTONIO RUSSO

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

  • Autori: Di Maida, F.; Mari, A.; Scalici Gesolfo, C.; Cangemi, A.; Allegro, R.; Sforza, S.; Cocci, A.; Tellini, R.; Masieri, L.; Russo, A.; Carini, M.; Minervini, A.; Serretta, V.
  • Anno di pubblicazione: 2019
  • Tipologia: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/359492

Abstract

The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.